1
项与 TCRαβ CD19 deplete Haplo-HSCT 相关的临床试验TCR Alpha/Beta and CD19-depleted Allogeneic Hematopoietic Cell Transplant for Malignant and Non-Malignant Disease
This is an open label, interventional, non-randomized, phase II trial of TCR alpha/beta and CD19-depeleted allogeneic HCT in pediatric patients with hematologic disease.
100 项与 TCRαβ CD19 deplete Haplo-HSCT 相关的临床结果
100 项与 TCRαβ CD19 deplete Haplo-HSCT 相关的转化医学
100 项与 TCRαβ CD19 deplete Haplo-HSCT 相关的专利(医药)
100 项与 TCRαβ CD19 deplete Haplo-HSCT 相关的药物交易